Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: December 14, 2011

Drug Name Review Type Class Manufacturer
Complera New Drug Initial Review HIV Gilead
Brilinta New Drug Initial Review Platelet Aggregation Inhibitor AstraZeneca
Edarbi New Drug Initial Review Angiotensin II Receptor Blocker Takeda
Daliresp New Drug Initial Review PDE4 Inhibitor Forest
Pradaxa New Drug Appeal Direct Thrombin Inhibitor Boehringer-Ingelheim
Incivek New Drug Appeal Hepatitis C Vertex
Onglyza New Drug Appeal DPP-4 Inhibitor BMS
Latuda New Drug Appeal Atypical Antipsychotic Sunovion
Exelon Patch PDL Appeal Alzheimers Novartis